Gan & Lee Pharmaceuticals Is A Beijing Based Company Founded In 1998Focused On Enhancing Human Health Through High Quality Pharmaceutical Productsthe Company Specializes In The Developmentproductionand Commercialization Of Insulin Analogs And Medical Devicesparticularly For Diabetes And Oncologytheir Product Lineup Includes Various Insulin Formulationssuch As Insulin Glargineinsulin Lisproand Insulin Aspartcatering To Different Patient Needs With A Commitment To Research And Developmentgan & Lee Aims To Establish Itself As A World Class Pharmaceutical Companythe Company Went Public In June 2020Raising Significant Capital And Achieving A Market Cap Of Approximately $27 66 Billionin 2023It Reported A Revenue Of $364 67 Million And Continues To Experience Growth In Its Financial Performancegan & Lee Pharmaceuticals Employs Around 4 482 Peoplecontributing To Its Mission Of Providing Effective Healthcare Solutions Globally
China
Nigeria
Germany
